Entry |
|
Name |
Autoimmune thyroid disease - Pan paniscus (bonobo)
|
Description |
The classification of autoimmune throid disease (AITD) includes Hashimoto's thyroiditis (HT) or chronic autoimmune thyroiditis and its variants, Graves' disease (GD) and autoimmune atrophic thyroiditis or primary myxedema. HT is characterized by the presence of goitre, thyroid autoantibodies against thyroid peroxidase (TPO) and thyroglobulin (Tg) in serum and varying degrees of thyroid dysfunction. During HT, self-reactive CD4+ T lymphocytes (Th) recruit B cells and CD8+ T cells (CTL) into the thyroid. Disease progression leads to the death of thyroid cells and hypothyroidism. Both autoantibodies and thyroid-specific cytotoxic T lymphocytes (CTLs) have been proposed to be responsible for autoimmune thyrocyte depletion. In GD, the TSH-R is the most important autoantigen. Antibodies directed against it mimic the effects of the hormone on thyroid cells, TSH, stimulating autonomous production of thyroxine and triiodothyronine and causing hyperthyroidism. The presence of TSH-R-blocking antibodies that bind the TSH receptor in a similar fashion to the antibodies in patients with Grave's disease but that block rather than activate the receptor explains some cases of atrophic hypothyroidism.
|
Class |
Human Diseases; Immune disease
|
Pathway map |

|
Organism |
Pan paniscus (bonobo) [GN: pps]
|
Gene |
100986750 | HLA class II histocompatibility antigen, DRB1-4 beta chain [KO:K06752] |
100987433 | HLA class II histocompatibility antigen, DRB1-10 beta chain-like [KO:K06752] |
100987081 | HLA class II histocompatibility antigen, DR alpha chain [KO:K06752] |
100967723 | HLA class II histocompatibility antigen, DO alpha chain [KO:K06752] |
100972641 | HLA class II histocompatibility antigen, DQ beta 2 chain [KO:K06752] |
100967376 | RLA class II histocompatibility antigen, DP alpha-1 chain-like [KO:K06752] |
100979649 | HLA class II histocompatibility antigen, DQ alpha 2 chain-like [KO:K06752] |
100968989 | HLA class II histocompatibility antigen, DM alpha chain [KO:K06752] |
100968410 | MHC-DMB; HLA class II histocompatibility antigen, DM beta chain [KO:K06752] |
100995577 | HLA class II histocompatibility antigen, DP alpha 1 chain [KO:K06752] |
100995226 | Papa-DPB1; HLA class II histocompatibility antigen, DP beta 1 chain [KO:K06752] |
100970847 | HLA class II histocompatibility antigen, DO beta chain [KO:K06752] |
100973583 | HLA class II histocompatibility antigen, DQ alpha 2 chain [KO:K06752] |
100972994 | HLA class II histocompatibility antigen, DQ beta 1 chain [KO:K06752] |
100993847 | HLA class II histocompatibility antigen, DQ beta 1 chain-like [KO:K06752] |
100993508 | HLA class II histocompatibility antigen, DQ alpha 1 chain [KO:K06752] |
100978457 | MHC-F; patr class I histocompatibility antigen, CH28 alpha chain [KO:K06751] |
100978112 | Papa-A; patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751] |
100979338 | HLA-H; putative HLA class I histocompatibility antigen, alpha chain H [KO:K06751] |
100978774 | MHC-G; patr class I histocompatibility antigen, alpha chain G [KO:K06751] |
100993452 | HLA class I histocompatibility antigen, A-3 alpha chain-like [KO:K06751] |
100977055 | patr class I histocompatibility antigen, alpha chain E [KO:K06751] |
100982294 | Papa-C; class I histocompatibility antigen, Gogo-C*0202 alpha chain [KO:K06751] |
100982859 | PAPA-B; class I histocompatibility antigen, Gogo-B*0101 alpha chain [KO:K06751] |
100979030 | putative V-set and immunoglobulin domain-containing-like protein IGHV1OR21-1 [KO:K06856] |
100970186 | putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 [KO:K06856] |
103785315 | putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 [KO:K06856] |
103785316 | putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 [KO:K06856] |
100989153 | putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 [KO:K06856] |
|
Compound |
D00636 | Amiodarone hydrochloride (JP17/USP) |
|
Reference |
|
Authors |
Fountoulakis S, Tsatsoulis A. |
Title |
On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis. |
Journal |
|
Reference |
|
Authors |
Chistiakov DA. |
Title |
Immunogenetics of Hashimoto's thyroiditis. |
Journal |
|
Reference |
|
Authors |
McIver B, Morris JC. |
Title |
The pathogenesis of Graves' disease. |
Journal |
|
Reference |
|
Authors |
Stassi G, De Maria R. |
Title |
Autoimmune thyroid disease: new models of cell death in autoimmunity. |
Journal |
|
Reference |
|
Authors |
Collins J, Gough S. |
Title |
Autoimmunity in thyroid disease. |
Journal |
|
Reference |
|
Authors |
Ruwhof C, Drexhage HA. |
Title |
Iodine and thyroid autoimmune disease in animal models. |
Journal |
|
Reference |
|
Authors |
Tsatsoulis A. |
Title |
The role of stress in the clinical expression of thyroid autoimmunity. |
Journal |
|
Reference |
|
Authors |
Prummel MF, Strieder T, Wiersinga WM. |
Title |
The environment and autoimmune thyroid diseases. |
Journal |
|
Reference |
|
Authors |
Kopp P. |
Title |
The TSH receptor and its role in thyroid disease. |
Journal |
|
Related pathway |
pps04610 | Complement and coagulation cascades |
pps04612 | Antigen processing and presentation |
pps04660 | T cell receptor signaling pathway |
pps04662 | B cell receptor signaling pathway |
|
KO pathway |
|